Vanguard Group
XERS icon

Vanguard Group’s Xeris Biopharma Holdings XERS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$45.8M Buy
9,816,937
+1,707,293
+21% +$7.97M ﹤0.01% 2160
2025
Q1
$44.5M Buy
8,109,644
+210,581
+3% +$1.16M ﹤0.01% 2139
2024
Q4
$26.8M Buy
7,899,063
+133,738
+2% +$453K ﹤0.01% 2444
2024
Q3
$22.1M Buy
7,765,325
+108,435
+1% +$309K ﹤0.01% 2545
2024
Q2
$17.2M Buy
7,656,890
+50,648
+0.7% +$114K ﹤0.01% 2646
2024
Q1
$16.8M Buy
7,606,242
+519,897
+7% +$1.15M ﹤0.01% 2684
2023
Q4
$16.7M Buy
7,086,345
+60,181
+0.9% +$141K ﹤0.01% 2676
2023
Q3
$13.1M Buy
7,026,164
+74,565
+1% +$139K ﹤0.01% 2724
2023
Q2
$18.2M Buy
6,951,599
+110,515
+2% +$290K ﹤0.01% 2632
2023
Q1
$11.2M Buy
6,841,084
+243,128
+4% +$396K ﹤0.01% 2877
2022
Q4
$8.78M Buy
6,597,956
+88,223
+1% +$117K ﹤0.01% 3012
2022
Q3
$10.2M Buy
6,509,733
+216,252
+3% +$337K ﹤0.01% 2945
2022
Q2
$9.69M Buy
6,293,481
+1,085,295
+21% +$1.67M ﹤0.01% 3004
2022
Q1
$13.3M Buy
5,208,186
+92,563
+2% +$237K ﹤0.01% 3000
2021
Q4
$15M Buy
5,115,623
+2,139,443
+72% +$6.27M ﹤0.01% 2990
2021
Q3
$7.29M Sell
2,976,180
-4,187
-0.1% -$10.3K ﹤0.01% 3425
2021
Q2
$12.1M Buy
2,980,367
+234,322
+9% +$954K ﹤0.01% 3111
2021
Q1
$12.4M Buy
2,746,045
+332,997
+14% +$1.5M ﹤0.01% 3034
2020
Q4
$11.9M Buy
2,413,048
+187,643
+8% +$923K ﹤0.01% 2907
2020
Q3
$13.2M Buy
2,225,405
+58,161
+3% +$345K ﹤0.01% 2650
2020
Q2
$5.77M Buy
2,167,244
+475,407
+28% +$1.26M ﹤0.01% 3034
2020
Q1
$3.3M Buy
1,691,837
+373,777
+28% +$729K ﹤0.01% 3151
2019
Q4
$9.29M Buy
1,318,060
+23,531
+2% +$166K ﹤0.01% 2893
2019
Q3
$12.7M Buy
1,294,529
+75,376
+6% +$741K ﹤0.01% 2703
2019
Q2
$13.9M Buy
1,219,153
+81,209
+7% +$929K ﹤0.01% 2680
2019
Q1
$11.4M Buy
1,137,944
+809,635
+247% +$8.13M ﹤0.01% 2756
2018
Q4
$5.58M Buy
328,309
+73,245
+29% +$1.25M ﹤0.01% 3039
2018
Q3
$4.48M Buy
255,064
+230,064
+920% +$4.04M ﹤0.01% 3276
2018
Q2
$474K Buy
+25,000
New +$474K ﹤0.01% 3830